Cynata Therapeutics Limited (51S)
FSX
0.00050
0.00 (0.00%)
Real-time Data
06:00 AM
Day's Range
0.000500.00050
52 wk Range
0.000500.2400
Financial Statements - 51S - Cynata Therapeutics Limited
Net Income
-9.39M▲ 3.6%
EBITDA
-11.21M▲ 8.6%
Free Cash Flow
-8.77M▲ 11.9%
Income Statement
| Period Ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|---|
| Sales | - | - | - | - | - | - |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | - | -11.49M | -12.54M | -16.54M | -13.83M | -5.14M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | 1.87M | 2.38M | 1.91M | 8.32M | 735.67K |
| Pre Tax Income | - | -9.39M | -9.74M | -14.27M | -5.44M | -4.35M |
| Income Tax | - | 0 | 0 | 0 | 0 | 0 |
| Net Income | - | -9.39M | -9.74M | -14.27M | -5.44M | -4.35M |
| EPS Basic | -0.0384 | -0.0458 | -0.0542 | -0.0984 | -0.038 | -0.059 |
| EPS Diluted | -0.0384 | -0.0458 | -0.0542 | -0.0984 | -0.038 | -0.059 |
| Basic Shares Outstanding | 236.70M | 204.95M | 179.63M | 145.09M | 143.27M | 73.89M |
| Diluted Shares Outstanding | 236.70M | 204.95M | 179.63M | 145.09M | 143.27M | 73.89M |
| Ebit | - | -11.49M | -12.54M | -16.54M | -13.83M | -5.14M |
| Ebitda | - | -11.21M | -12.26M | -16.26M | -13.55M | -4.98M |
| Net Income Continuous Operations | - | - | - | - | - | - |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
